Țară: Japonia
Limbă: engleză
Sursă: すりの適正使用協議会 RAD-AR Council, Japan
Nivolumab (genetical recombination)
Bristol-Myers Squibb
Nivolumab (genetical recombination)
injection
Drug Information Sheet("Kusuri-no-Shiori") Injection Revised: 02/2024 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: OPDIVO INTRAVENOUS INFUSION 20MG ACTIVE INGREDIENT: Nivolumab (genetical recombination) DOSAGE FORM: injection IMPRINT OR PRINT ON WRAPPING: EFFECTS OF THIS MEDICINE This medicine inhibits binding of cancer cell to T-cell (immune cell) via PD-1 receptor and promotes T-cell activation. It consequently enhances immune response to cancer and shows antitumor effect. It is usually used to treat malignant melanoma, unresectable advanced/recurrent non-small cell lung cancer, neoadjuvant treatment of non-small cell lung cancer, radically unresectable or metastatic renal cell carcinoma, recurrent or refractory classical Hodgkin's lymphoma, recurrent or distant metastatic head and neck cancer, unresectable advanced/recurrent gastric cancer, unresectable advanced/recurrent malignant pleural mesothelioma, malignant mesothelioma(excluding malignant pleural mesothelioma), microsatellite instability high (MSI-High) unresectable advanced/recurrent colorectal cancer progressing after cancer chemotherapy, radically unresectable advanced/recurrent esophageal cancer, adjuvant treatment of esophageal cancer, cancer of unknown primary, adjuvant treatment of urothelial cancer and radically unresectable advanced/recurrent malignant epithelial tumors. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines or foods. If you have autoimmune disorder or its history, or interstitial pulmonary disease or its history, Citiți documentul complet